LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_005359.6:c.454+23C>T
SMAD4
· NP_005350.1:p.?
· NM_005359.6
GRCh37: chr18:48575717 C>T
·
GRCh38: chr18:51049347 C>T
Gene:
SMAD4
Transcript:
NM_005359.6
Final call
VUS
BP4 supporting
Variant details
Gene
SMAD4
Transcript
NM_005359.6
Protein
NP_005350.1:p.?
gnomAD AF
0.00030292138142310815 (v4.1)
ClinVar
Likely benign
OncoKB
Classification rationale
Interpretation summary
Generated evidence synthesis
1
VUS: BP4 (supporting) was met because SpliceAI maximum delta 0.008 is below the <=0.1 threshold for no significant predicted splice impact.
Final determination:
Under generic ACMG/AMP 2015 fallback rules, one supporting benign criterion alone does not meet the Likely Benign threshold of two supporting benign criteria, so the result is VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: c.454+23C>T is a non-canonical intronic variant with SpliceAI max delta 0.008 and no demonstrated protein-truncating or splice-loss consequence. |
pvs1_generic_framework
spliceai
PMID:25741868
|
| PS1 | N/A | Not applicable: this intronic variant has unknown protein consequence and is not an amino-acid substitution. |
|
| PS2 | Not assessed | Not assessed: no documented parental testing or confirmed de novo occurrence is available for this variant. |
PMID:25741868
|
| PS3 | Not assessed | Not assessed: no variant-specific validated functional assay or assay result is available for NM_005359.6:c.454+23C>T. |
PMID:25741868
|
| PS4 | Not assessed | Not assessed: no case-control cohort, odds ratio, or exact-variant prevalence comparison is available to establish affected-individual enrichment. |
|
| PM1 | N/A | Not applicable: the intronic variant has unknown protein consequence, so no amino-acid residue can be evaluated for a critical domain or hotspot. |
|
| PM2 | Not met | Not met: gnomAD v4.1 overall AF 0.000302921 exceeds the generic PM2 threshold of 0.0001. |
gnomad_v4
gnomad_v2
PMID:25741868
|
| PM3 | Not assessed | Not assessed: no affected-proband observation, second pathogenic variant, phase result, or inheritance information is documented for this intronic SMAD4 variant. |
|
| PM4 | N/A | Not applicable: the intronic SNV has protein consequence p.? and produces no established in-frame insertion, deletion, or protein-length change. |
|
| PM5 | N/A | Not applicable: the intronic variant has unknown protein consequence, so no amino-acid residue exists for PM5 same-residue comparison. |
|
| PM6 | Not assessed | Not assessed: no affected proband with a presumed de novo variant is documented, even without parental confirmation. |
PMID:25741868
|
| PP1 | Not assessed | Not assessed: zero informative affected-relative genotypes or meioses are documented for segregation analysis. |
PMID:25741868
|
| PP2 | N/A | Not applicable: PP2 is a missense criterion, whereas this variant is intronic with unknown protein consequence. |
|
| PP3 | Not met | Not met: SpliceAI maximum delta 0.008 is below the >=0.2 supporting PP3 threshold. |
spliceai
|
| PP4 | Not assessed | Not assessed: no patient phenotype, clinical diagnosis, or disease-specific family history is available to establish a highly specific phenotype match. |
|
| PP5 | Not met | Not met: the exact ClinVar record has zero expert-panel submissions and only single-submitter Likely benign assertions. |
clinvar
|
| BA1 | Not met | Not met: the highest default all-comers gnomAD v4.1 population AF is 0.005251535, below the generic BA1 threshold of 0.05. |
gnomad_v4
gnomad_v2
PMID:25741868
|
| BS1 | Not met | Not met: the highest default all-comers gnomAD v4.1 population AF is 0.005251535, below the generic BS1 threshold of 0.01. |
gnomad_v4
gnomad_v2
|
| BS2 | Not assessed | Not assessed: one gnomAD homozygote is reported, but age, phenotype, and clinical health of that individual are unavailable. |
gnomad_v2
gnomad_v4
|
| BS3 | Not assessed | Not assessed: no variant-specific validated functional assay or assay result is available to demonstrate preserved function for NM_005359.6:c.454+23C>T. |
PMID:25741868
|
| BS4 | Not assessed | Not assessed: no affected-family testing or documented non-segregation observation is available for this variant. |
PMID:25741868
|
| BP1 | N/A | Not applicable: BP1 concerns missense variants, but this submitted variant is intronic with unknown protein consequence. |
|
| BP2 | Not assessed | Not assessed: no additional pathogenic variant or validated cis/trans phase result is documented for this intronic SMAD4 variant. |
|
| BP3 | N/A | Not applicable: c.454+23C>T is an intronic SNV, not an in-frame deletion in a repetitive protein region. |
|
| BP4 | Met | Met, supporting: SpliceAI maximum delta 0.008 is below the <=0.1 BP4 threshold. |
spliceai
|
| BP5 | Not assessed | Not assessed: no affected-individual phenotype or confirmed alternate molecular diagnosis is documented for this exact variant. |
|
| BP6 | Not met | Not met: the exact ClinVar record has zero expert-panel submissions and only single-submitter Likely benign assertions. |
clinvar
|
| BP7 | N/A | Not applicable: c.454+23C>T is intronic, not a synonymous coding variant eligible for BP7. |
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.